Figure 1.
a) Number of genomic alterations in fusion-positive versus fusion-negative rhabdomyosarcoma (p=0.007) and b) tumor mutational burden (TMB) in fusion-positive versus fusion-negative rhabdomyosarcoma (p=0.01)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.